Semaglutide 2.4 mg in adults with overweight or obesity: A double-blind, randomised, placebo-controlled trial
The burden of DM is compounded by common comorbidities such as atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD), which affect nearly one-third of individuals with DM [1, 2]
Medication availability, pharmacy fulfillment, dosage, and eligibility depend on clinician review and applicable pharmacy and regulatory requirements
Additionally, glutathione may influence melanin production in the skin, meaning it may offer potential skin lightening properties
This initiative aims to spread awareness about cardiovascular diseases (CVDs), which are the leading cause of death worldwide, claiming over 17.9 million lives annually